PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 69 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q2 2014 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q1 2014 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 220 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delaney Dennis R | 60,000 | $25,000 | 0.05% |
| Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
| Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
| CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
| First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
| Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
| QS Investors, LLC | 503,400 | $212,000 | 0.00% |
| Perceptive Advisors | 24,332 | $10,000 | 0.00% |